ASTELLAS PHARMA A/S — Credit Rating and Financial Key Figures

ASTELLAS PHARMA A/S (CVR number: 10888638) is a company from KØBENHAVN. The company reported a net sales of 186.9 mEUR in 2023, demonstrating a growth of 3.3 % compared to the previous year. The operating profit percentage was at 3.2 % (EBIT: 5.9 mEUR), while net earnings were 4470 kEUR. The profitability of the company measured by Return on Assets (ROA) was 16.1 %, which can be considered excellent but Return on Equity (ROE) was 14.9 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 24.5 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. ASTELLAS PHARMA A/S's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.